cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.22771031
title: Traditional Chinese medicine lifestyle intervention for chronic insomnia: raw data from a multicenter, parallel, open randomized controlled clinical trial.zip

description: <strong>Background:</strong> Traditional Chinese Medicine (TCM) lifestyle interventions are believed to assist in improving sleep. However, large-scale clinical trials confirming their effectiveness and safety are lacking. Therefore a multicenter, parallel, randomized controlled trial was conducted in China. <strong>Methods:</strong> The music therapy combined with TCM group listened to music combined with sleeping drinks and sleeping pillows which were made of TCM. Music therapy alone group only listened to music. The primary outcome was the change from baseline in the Pittsburgh Sleep Quality Index (PSQI) at weeks 4, 8, and 12. Secondary outcomes were the change from baseline in the Fatigue Scale-14 (FS-14), Hyperarousal Scale (HAS), and Insomnia Severity Index Scale (ISI) total scores at weeks 4, 8, and 12. Both groups intervened for 12 weeks. Generalized estimating equations were used for statistics, and the Full analysis set(FAS)was used to analyze the data along with the Per Protocol Set (PPS). <strong>Results</strong>: After 12 weeks of treatment, significant improvements were observed in the TCM intervention combined with the music group for both primary and secondary outcomes, but the treatment advantage only became apparent at weeks 8 and 12. In terms of safety analysis, there were no serious adverse effects. <strong>Conclusion</strong>: TCM interventions to assist in the treatment of chronic insomnia are effective and safe.
DOI: 10.6084/m9.figshare.22771031.v1
title: Traditional Chinese medicine lifestyle intervention for chronic insomnia: raw data from a multicenter, parallel, open randomized controlled clinical trial.zip

description: <strong>Background:</strong> Traditional Chinese Medicine (TCM) lifestyle interventions are believed to assist in improving sleep. However, large-scale clinical trials confirming their effectiveness and safety are lacking. Therefore a multicenter, parallel, randomized controlled trial was conducted in China. <strong>Methods:</strong> The music therapy combined with TCM group listened to music combined with sleeping drinks and sleeping pillows which were made of TCM. Music therapy alone group only listened to music. The primary outcome was the change from baseline in the Pittsburgh Sleep Quality Index (PSQI) at weeks 4, 8, and 12. Secondary outcomes were the change from baseline in the Fatigue Scale-14 (FS-14), Hyperarousal Scale (HAS), and Insomnia Severity Index Scale (ISI) total scores at weeks 4, 8, and 12. Both groups intervened for 12 weeks. Generalized estimating equations were used for statistics, and the Full analysis set(FAS)was used to analyze the data along with the Per Protocol Set (PPS). <strong>Results</strong>: After 12 weeks of treatment, significant improvements were observed in the TCM intervention combined with the music group for both primary and secondary outcomes, but the treatment advantage only became apparent at weeks 8 and 12. In terms of safety analysis, there were no serious adverse effects. <strong>Conclusion</strong>: TCM interventions to assist in the treatment of chronic insomnia are effective and safe.
DOI: 10.5281/zenodo.4061985
title: Supporting Data Ferguson, Camenzind, et al., "Measurement-induced induced population switching", Phys. Rev. Research 5, 023028 (2023)

description: This repository contains data for the publication "Measurement-induced population switching", Phys. Rev. Research 5, 023028 (2023) by Ferguson, Camenzind, <em>et al</em>. <strong>Abstract</strong> Quantum information processing is a key technology in the ongoing second quantum revolution, with a wide variety of hardware platforms competing toward its realization. An indispensable component of such hardware is a measurement device, i.e., a quantum detector that is used to determine the outcome of a computation. The act of measurement in quantum mechanics, however, is naturally invasive as the measurement apparatus becomes entangled with the system that it observes. This always leads to a disturbance in the observed system, a phenomenon called quantum measurement backaction, which should solely lead to the collapse of the quantum wave function and the physical realization of the measurement postulate of quantum mechanics. Here we demonstrate that backaction can fundamentally change the quantum system through the detection process. For quantum information processing, this means that the readout alters the system in such a way that a faulty measurement outcome is obtained. Specifically, we report a backaction-induced population switching, where the bare presence of weak, nonprojective measurements by an adjacent charge sensor inverts the electronic charge configuration of a semiconductor double quantum dot system. The transition region grows with measurement strength and is suppressed by temperature, in excellent agreement with our coherent quantum backaction model. Our result exposes backaction channels that appear at the interplay between the detector and the system environments, and opens new avenues for controlling and mitigating backaction effects in future quantum technologies.
DOI: 10.6084/m9.figshare.22811132
title: Influence of mechanochemical treatment and oxygen inhibited layer on the adhesion of self-adhesive resin cement to bulk-fill composite resin- additonal documents

description: Addtional documents including raw data and tables
DOI: 10.6084/m9.figshare.22811132.v1
title: Influence of mechanochemical treatment and oxygen inhibited layer on the adhesion of self-adhesive resin cement to bulk-fill composite resin- additonal documents

description: Addtional documents including raw data and tables
DOI: 10.25345/c5pg1hz53
title: MassIVE MSV000091925 - GNPS-METABLOMICSDDDDDDDD111111112
title: METABLOMIC STUDY OF MS MS DATA OF TERMINALIA CHEBULA
DOI: 10.5281/zenodo.7678773
title: Giardia hinders growth by disrupting nutrient metabolism independent of inflammatory enteropathy

description: NMR Data used in the manuscript
DOI: 10.5281/zenodo.7678772
title: Giardia hinders growth by disrupting nutrient metabolism independent of inflammatory enteropathy

description: NMR Data used in the manuscript
DOI: 10.48420/22787444.v1
title: Raw Data for 'The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer'.

description: One Excel file consisting of raw data from the paper 'The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer' by Rees et al. 09MAY2023. <br> The Excel file is divided into tabs showing the raw data used for each of the Figures presented in the paper, e.g. Tab 1 = Figure 1A. Each tab contains a header row identifying the colorectal cancer cell line used and the experiment conditions. <br> Figures 1 provides the raw data for proliferation experiments conducted using the colorectal cancer cell lines SW620 and DLD-1 with the addition of the coagulation factors thrombin (Fig 1A/1B), factor Xa (Fig 1C/1D) and tissue factor (Fig 1E/1F). Fold change in fluorescence normalised to time point 0 hours is shown. <br> Figure 2 provides the raw data for proliferation experiments conducted using the colorectal cancer cell line SW620 with the addition of the coagulation factor thrombin and its inhibitor dabigatran, solely and in combination, plus its untreated vehicle control. Fold change in fluorescence normalised to time point 0 hours is shown. <br> Figure 3 provides the raw data for migration experiments conducted using the colorectal cancer cell line DLD-1 with the addition of the coagulation factors thrombin (Fig 3A), factor Xa (Fig 3B) and tissue factor (Fig 3C). Number of migrated cells per x200 field on light microscopy is shown. <br> Figure 4 provides the raw data for migration experiments conducted using the colorectal cancer cell line DLD-1 with the addition of the coagulation factors and their respective inhibitors: thrombin and dabigatran (Fig 4A), factor Xa and rivaroxaban (Fig 4B) and tissue factor and anti-tissue factor antibody 10H10 (Fig 4C). Number of migrated cells per x200 field on light microscopy is shown.
DOI: 10.5281/zenodo.7929023
title: KAGE Yeast Whole Genome Dataset

description: A yeast whole genome dataset for testing in KAGE indexing: https://github.com/ivargr/kage-indexing
DOI: 10.5281/zenodo.7929022
title: KAGE Yeast Whole Genome Dataset

description: A yeast whole genome dataset for testing in KAGE indexing: https://github.com/ivargr/kage-indexing
DOI: 10.6084/m9.figshare.22811117
title: Table S2.

description: Table S2. Count of transposable elements overlapping the gene coding regions among 58 fungi for 6 PFAM domains. The following TE families are included for the analysis, DNA transpososns (DNA), retrotransposon with long terminal repeats (LTR), retroposons with long interspersed nuclear elements (LINE), retroposon with short interspersed nuclear elements (SINE), and rolling-circle/helitron transposons (RC). Unclassified TEs (unknown) were excluded.
DOI: 10.6084/m9.figshare.22811117.v1
title: Table S2.

description: Table S2. Count of transposable elements overlapping the gene coding regions among 58 fungi for 6 PFAM domains. The following TE families are included for the analysis, DNA transpososns (DNA), retrotransposon with long terminal repeats (LTR), retroposons with long interspersed nuclear elements (LINE), retroposon with short interspersed nuclear elements (SINE), and rolling-circle/helitron transposons (RC). Unclassified TEs (unknown) were excluded.
DOI: 10.5281/zenodo.7928777
title: Yeast Genome Test Dataset

description: Dataset used for tests for kage-indexing: https://github.com/ivargr/kage-indexing
DOI: 10.5281/zenodo.7928778
title: Yeast Genome Test Dataset

description: Dataset used for tests for kage-indexing: https://github.com/ivargr/kage-indexing
DOI: 10.5281/zenodo.7929047
title: Yeast Genome Test Dataset

description: Dataset used for tests for kage-indexing: https://github.com/ivargr/kage-indexing
DOI: 10.6084/m9.figshare.22056905.v2
title: TableS3.xlsx

description: Mycena enriched clusters in COMPARE analyses.
DOI: 10.5281/zenodo.7927933
title: Deep convection induce strong proto-Antarctic Circumpolar Current

description: This dataset includes model outputs of a high-resolution model with realistic late Eocene topography, which is applied to test the sensitivity of the proto-ACC to late Eocene and modern surface buoyancy forcing. The included data can be used to analyse temperature, salinity, zonal velocity distribution, eddy kinetic energy, and mixed layer depth in late Eocene Southern Ocean.
DOI: 10.6084/m9.figshare.22056968
title: TableS8.xlsx

description: Table S6. Strain, ecological information, MUCL deposition identifiers, genomic data overview and sources of publication for pre-existing genomes.
DOI: 10.6084/m9.figshare.22056968.v2
title: TableS7.xlsx

description: Table S6. Strain, ecological information, MUCL deposition identifiers, genomic data overview and sources of publication for pre-existing genomes.
DOI: 10.6084/m9.figshare.22056968.v3
title: TableS8.xlsx

description: Table S6. Strain, ecological information, MUCL deposition identifiers, genomic data overview and sources of publication for pre-existing genomes.
DOI: 10.6084/m9.figshare.22056953
title: TableS7.xlsx

description: Table 5. Permanova values and summaries.
DOI: 10.6084/m9.figshare.22056953.v3
title: TableS7.xlsx

description: Table 5. Permanova values and summaries.
DOI: 10.6084/m9.figshare.22056953.v2
title: TableS6.xlsx

description: Table 5. Permanova values and summaries.
DOI: 10.6084/m9.figshare.22056950
title: TableS6.xlsx

description: Orthology in Mycena.
DOI: 10.6084/m9.figshare.22056950.v3
title: TableS6.xlsx

description: Orthology in Mycena.
DOI: 10.6084/m9.figshare.22056950.v2
title: TableS5.xlsx

description: Orthology in Mycena.
DOI: 10.6084/m9.figshare.22056905
title: TableS5.xlsx

description: Mycena enriched clusters in COMPARE analyses.
DOI: 10.6084/m9.figshare.22056905.v4
title: TableS5.xlsx

description: Mycena enriched clusters in COMPARE analyses.
DOI: 10.6084/m9.figshare.22056905.v3
title: TableS4.xlsx

description: Mycena enriched clusters in COMPARE analyses.
DOI: 10.4121/7a692e36-c32f-4916-813b-c62d2566e8d8.v2
title: Commercial microwave link data for rainfall monitoring

description: Dataset of commercial microwave link (CML) data, which can be used to estimate path-average rainfall between telephone towers. Contains microwave frequency, end date & time of reading, minimum & maximum received power, path length, coordinates, and link identifier. For a network of on average ~2500 links covering the Netherlands having a temporal resolution of 15 min. The dataset, which consists of two files, can be used with the open-source R package RAINLINK (https://github.com/overeem11/RAINLINK) to estimate path-averaged rainfall and to make rainfall maps. Data have been used in the mentioned papers under "link to publication", but these use either a subset of the dataset or also other data.<br><br>
DOI: 10.6084/m9.figshare.22811279
title: Supplementary Material for: Intrauterine Blood Transfusion for Parvo B19 Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes

description: INTRODUCTION: We aimed to evaluate neuroimaging findings and long-term neurodevelopment of fetuses and children following intrauterine blood transfusion [IUT] for parvo B19 infection induced anemia compared to those with RBC alloimmunization. METHODS: We conducted a retrospective cohort study including women who underwent an IUT due to fetal anemia between 2006 to 2019 in a tertiary, university-affiliated medical center. The cohort was divided into two: a study group - fetuses affected by congenital parvo-B19 infection; and a control group - fetuses affected by RBC alloimmunization. Retrospective data such as antenatal sonographic evaluations, fetal brain MRI results and short-term fetal and neonatal outcomes were collected. All children underwent a neurodevelopmental evaluation after birth using a Vineland questionnaire. Primary outcome was defined as the presence or absence of neurodevelopmental delay. Secondary outcome was defined as the presence of abnormal fetal neuroimaging findings such as cerebellar hypoplasia, polymicrogyria, intracranial hemorrhage or severe ventriculomegaly. RESULTS: Overall, 71 fetuses requiring at least one IUT were included in the study. Of these, 18 were affected by parvo B19 infection and 53 by RBC alloimmunization with various associated antibodies. Fetuses in the parvo B19 group presented at an earlier gestational age [22.91 ± 3.36 weeks vs. 27.37 ± 4.67 weeks, p=0.002] and were more affected by hydrops [93.33% vs. 16.98%, p&lt;0.001]. Three fetuses out of the 18[16.67%] fetuses in the parvo B19 group died in utero following the IUT. Abnormal neuro-imaging findings were detected in 4/15 [26.7%] of the parvo B19 survivors vs. 2/ 53 [3.8%] of fetuses affected by RBC alloimmunization [p=0.005]. There was no difference in long-term neurodevelopmental delay rates between the children in the study and control groups, as assessed at the average age of 3.65 and 6.53 years, accordingly. CONCLUSION: Fetal anemia due to parvo B19, treated with IUT, might be associated with increased rates of abnormal neuro-sonographic findings. The correlation between those findings and long-term adverse neuro-developmental outcomes requires further investigation
DOI: 10.6084/m9.figshare.22811279.v1
title: Supplementary Material for: Intrauterine Blood Transfusion for Parvo B19 Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes

description: INTRODUCTION: We aimed to evaluate neuroimaging findings and long-term neurodevelopment of fetuses and children following intrauterine blood transfusion [IUT] for parvo B19 infection induced anemia compared to those with RBC alloimmunization. METHODS: We conducted a retrospective cohort study including women who underwent an IUT due to fetal anemia between 2006 to 2019 in a tertiary, university-affiliated medical center. The cohort was divided into two: a study group - fetuses affected by congenital parvo-B19 infection; and a control group - fetuses affected by RBC alloimmunization. Retrospective data such as antenatal sonographic evaluations, fetal brain MRI results and short-term fetal and neonatal outcomes were collected. All children underwent a neurodevelopmental evaluation after birth using a Vineland questionnaire. Primary outcome was defined as the presence or absence of neurodevelopmental delay. Secondary outcome was defined as the presence of abnormal fetal neuroimaging findings such as cerebellar hypoplasia, polymicrogyria, intracranial hemorrhage or severe ventriculomegaly. RESULTS: Overall, 71 fetuses requiring at least one IUT were included in the study. Of these, 18 were affected by parvo B19 infection and 53 by RBC alloimmunization with various associated antibodies. Fetuses in the parvo B19 group presented at an earlier gestational age [22.91 ± 3.36 weeks vs. 27.37 ± 4.67 weeks, p=0.002] and were more affected by hydrops [93.33% vs. 16.98%, p&lt;0.001]. Three fetuses out of the 18[16.67%] fetuses in the parvo B19 group died in utero following the IUT. Abnormal neuro-imaging findings were detected in 4/15 [26.7%] of the parvo B19 survivors vs. 2/ 53 [3.8%] of fetuses affected by RBC alloimmunization [p=0.005]. There was no difference in long-term neurodevelopmental delay rates between the children in the study and control groups, as assessed at the average age of 3.65 and 6.53 years, accordingly. CONCLUSION: Fetal anemia due to parvo B19, treated with IUT, might be associated with increased rates of abnormal neuro-sonographic findings. The correlation between those findings and long-term adverse neuro-developmental outcomes requires further investigation
DOI: 10.6084/m9.figshare.22811282
title: Supplementary Material for: Intrauterine Blood Transfusion for Parvo B19 Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes

description: INTRODUCTION: We aimed to evaluate neuroimaging findings and long-term neurodevelopment of fetuses and children following intrauterine blood transfusion [IUT] for parvo B19 infection induced anemia compared to those with RBC alloimmunization. METHODS: We conducted a retrospective cohort study including women who underwent an IUT due to fetal anemia between 2006 to 2019 in a tertiary, university-affiliated medical center. The cohort was divided into two: a study group - fetuses affected by congenital parvo-B19 infection; and a control group - fetuses affected by RBC alloimmunization. Retrospective data such as antenatal sonographic evaluations, fetal brain MRI results and short-term fetal and neonatal outcomes were collected. All children underwent a neurodevelopmental evaluation after birth using a Vineland questionnaire. Primary outcome was defined as the presence or absence of neurodevelopmental delay. Secondary outcome was defined as the presence of abnormal fetal neuroimaging findings such as cerebellar hypoplasia, polymicrogyria, intracranial hemorrhage or severe ventriculomegaly. RESULTS: Overall, 71 fetuses requiring at least one IUT were included in the study. Of these, 18 were affected by parvo B19 infection and 53 by RBC alloimmunization with various associated antibodies. Fetuses in the parvo B19 group presented at an earlier gestational age [22.91 ± 3.36 weeks vs. 27.37 ± 4.67 weeks, p=0.002] and were more affected by hydrops [93.33% vs. 16.98%, p&lt;0.001]. Three fetuses out of the 18[16.67%] fetuses in the parvo B19 group died in utero following the IUT. Abnormal neuro-imaging findings were detected in 4/15 [26.7%] of the parvo B19 survivors vs. 2/ 53 [3.8%] of fetuses affected by RBC alloimmunization [p=0.005]. There was no difference in long-term neurodevelopmental delay rates between the children in the study and control groups, as assessed at the average age of 3.65 and 6.53 years, accordingly. CONCLUSION: Fetal anemia due to parvo B19, treated with IUT, might be associated with increased rates of abnormal neuro-sonographic findings. The correlation between those findings and long-term adverse neuro-developmental outcomes requires further investigation
DOI: 10.6084/m9.figshare.22811282.v1
title: Supplementary Material for: Intrauterine Blood Transfusion for Parvo B19 Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes

description: INTRODUCTION: We aimed to evaluate neuroimaging findings and long-term neurodevelopment of fetuses and children following intrauterine blood transfusion [IUT] for parvo B19 infection induced anemia compared to those with RBC alloimmunization. METHODS: We conducted a retrospective cohort study including women who underwent an IUT due to fetal anemia between 2006 to 2019 in a tertiary, university-affiliated medical center. The cohort was divided into two: a study group - fetuses affected by congenital parvo-B19 infection; and a control group - fetuses affected by RBC alloimmunization. Retrospective data such as antenatal sonographic evaluations, fetal brain MRI results and short-term fetal and neonatal outcomes were collected. All children underwent a neurodevelopmental evaluation after birth using a Vineland questionnaire. Primary outcome was defined as the presence or absence of neurodevelopmental delay. Secondary outcome was defined as the presence of abnormal fetal neuroimaging findings such as cerebellar hypoplasia, polymicrogyria, intracranial hemorrhage or severe ventriculomegaly. RESULTS: Overall, 71 fetuses requiring at least one IUT were included in the study. Of these, 18 were affected by parvo B19 infection and 53 by RBC alloimmunization with various associated antibodies. Fetuses in the parvo B19 group presented at an earlier gestational age [22.91 ± 3.36 weeks vs. 27.37 ± 4.67 weeks, p=0.002] and were more affected by hydrops [93.33% vs. 16.98%, p&lt;0.001]. Three fetuses out of the 18[16.67%] fetuses in the parvo B19 group died in utero following the IUT. Abnormal neuro-imaging findings were detected in 4/15 [26.7%] of the parvo B19 survivors vs. 2/ 53 [3.8%] of fetuses affected by RBC alloimmunization [p=0.005]. There was no difference in long-term neurodevelopmental delay rates between the children in the study and control groups, as assessed at the average age of 3.65 and 6.53 years, accordingly. CONCLUSION: Fetal anemia due to parvo B19, treated with IUT, might be associated with increased rates of abnormal neuro-sonographic findings. The correlation between those findings and long-term adverse neuro-developmental outcomes requires further investigation